174 related articles for article (PubMed ID: 25985960)
1. Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Honkoop AH; Los M; van der Graaf WT; Stalmeier PF
J Cancer Educ; 2016 Sep; 31(3):443-8. PubMed ID: 25985960
[TBL] [Abstract][Full Text] [Related]
2. Expected survival with and without second-line palliative chemotherapy: who wants to know?
Oostendorp LJ; Ottevanger PB; van de Wouw AJ; Schoenaker IJ; de Graaf H; van der Graaf WT; Stalmeier PF
Health Expect; 2015 Dec; 18(6):2903-14. PubMed ID: 25302963
[TBL] [Abstract][Full Text] [Related]
3. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients' preferences.
Henselmans I; Van Laarhoven HW; Van der Vloodt J; De Haes HC; Smets EM
Palliat Med; 2017 Jul; 31(7):625-633. PubMed ID: 28618897
[TBL] [Abstract][Full Text] [Related]
4. Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial.
Oostendorp LJM; Ottevanger PB; Donders ART; van de Wouw AJ; Schoenaker IJH; Smilde TJ; van der Graaf WTA; Stalmeier PFM
BMC Med Inform Decis Mak; 2017 Aug; 17(1):130. PubMed ID: 28859646
[TBL] [Abstract][Full Text] [Related]
5. Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol.
Oostendorp LJ; Ottevanger PB; van der Graaf WT; Stalmeier PF
BMC Med Inform Decis Mak; 2011 Feb; 11():9. PubMed ID: 21320319
[TBL] [Abstract][Full Text] [Related]
6. How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter.
Elit LM; Charles C; Gafni A; Ranford J; Tedford-Gold S; Gold I
Health Expect; 2015 Oct; 18(5):1066-80. PubMed ID: 23663240
[TBL] [Abstract][Full Text] [Related]
7. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
[TBL] [Abstract][Full Text] [Related]
8. Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy.
Grunfeld EA; Maher EJ; Browne S; Ward P; Young T; Vivat B; Walker G; Wilson C; Potts HW; Westcombe AM; Richards MA; Ramirez AJ
J Clin Oncol; 2006 Mar; 24(7):1090-8. PubMed ID: 16505428
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Patients' Preferences for Truth Versus Hope Are Dynamic and Change During Late Lines of Palliative Chemotherapy.
Bergqvist J; Strang P
J Pain Symptom Manage; 2019 Apr; 57(4):746-752. PubMed ID: 30639732
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer.
Chiew KS; Shepherd H; Vardy J; Tattersall MH; Butow PN; Leighl NB
Health Expect; 2008 Mar; 11(1):35-45. PubMed ID: 18297781
[TBL] [Abstract][Full Text] [Related]
11. Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision-making perspective.
Pieterse AH; Kunneman M; Engelhardt EG; Brouwer NJ; Kroep JR; Marijnen CAM; Stiggelbout AM; Smets EMA
Psychooncology; 2017 Jul; 26(7):943-950. PubMed ID: 27502561
[TBL] [Abstract][Full Text] [Related]
12. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06).
Strasser F; Blum D; von Moos R; Cathomas R; Ribi K; Aebi S; Betticher D; Hayoz S; Klingbiel D; Brauchli P; Haefner M; Mauri S; Kaasa S; Koeberle D;
Ann Oncol; 2016 Feb; 27(2):324-32. PubMed ID: 26646758
[TBL] [Abstract][Full Text] [Related]
13. Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer.
Stone RL; Cambron-Mellott MJ; Beusterien K; Maculaitis MC; Ritz S; Mulvihill E; Monberg M; Szamreta EA; Amin S; McLaurin K
Future Oncol; 2022 Feb; 18(4):491-503. PubMed ID: 34875854
[TBL] [Abstract][Full Text] [Related]
14. Reflections on communication of disease prognosis and life expectancy by patients with colorectal cancer undergoing palliative care: a qualitative study.
Rohde G; Söderhamn U; Vistad I
BMJ Open; 2019 Mar; 9(3):e023463. PubMed ID: 30850402
[TBL] [Abstract][Full Text] [Related]
15. Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study.
Janssens A; Derijcke S; Lefebure A; Vandenbroucke E; Surmont V; Coeman D; Galdermans D; Morel AM; Hiddinga BI; van Meerbeeck JP
Clin Lung Cancer; 2017 Jul; 18(4):e283-e287. PubMed ID: 28189594
[TBL] [Abstract][Full Text] [Related]
16. How Does a Shared Decision-Making (SDM) Intervention for Oncologists Affect Participation Style and Preference Matching in Patients with Breast and Colon Cancer?
Bieber C; Nicolai J; Gschwendtner K; Müller N; Reuter K; Buchholz A; Kallinowski B; Härter M; Eich W
J Cancer Educ; 2018 Jun; 33(3):708-715. PubMed ID: 27966192
[TBL] [Abstract][Full Text] [Related]
17. Meeting the decision-making preferences of patients with breast cancer in oncology consultations: impact on decision-related outcomes.
Brown R; Butow P; Wilson-Genderson M; Bernhard J; Ribi K; Juraskova I
J Clin Oncol; 2012 Mar; 30(8):857-62. PubMed ID: 22312102
[TBL] [Abstract][Full Text] [Related]
18. Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer.
Hull O; Niranjan SJ; Wallace AS; Williams BR; Turkman YE; Ingram SA; Williams CP; Smith T; Knight SJ; Bhatia S; Rocque GB
Breast Cancer Res Treat; 2020 Nov; 184(1):115-121. PubMed ID: 32737711
[TBL] [Abstract][Full Text] [Related]
19. Information needs and decision-making preferences: comparing findings for gynaecological, breast and colorectal cancer.
Beaver K; Booth K
Eur J Oncol Nurs; 2007 Dec; 11(5):409-16. PubMed ID: 17604693
[TBL] [Abstract][Full Text] [Related]
20. Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.
Koedoot CG; De Haes JC; Heisterkamp SH; Bakker PJ; De Graeff A; De Haan RJ
J Clin Oncol; 2002 Sep; 20(17):3658-64. PubMed ID: 12202667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
